Precipio and University of Pennsylvania Enter into Joint Collaboration Agreement for Pathology Diagnostics
05 sept. 2019 09h15 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Specialty Diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today a major development toward expanding cancer patient access to world...
Precipio Pathology Sales Metrics Demonstrate Continuous Improvement in Q2 2019
13 août 2019 11h30 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced the results of three key performance metrics that together...
Precipio Signs Exclusive Manufacturing Agreement for IV-Cell™
04 juin 2019 09h10 HE
|
Precipio, Inc.
NEW HAVEN, Conn., June 04, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has entered into an exclusive subcontracting manufacturing...
Precipio CEO enrolls in long term stock purchase plan
23 mai 2019 09h55 HE
|
Precipio, Inc.
NEW HAVEN, Conn., May 23, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that, as previously stated, Ilan Danieli, Precipio’s CEO, has enrolled...
Precipio Reminder of Corporate Update Shareholder Call
01 mai 2019 18h06 HE
|
Precipio, Inc.
NEW HAVEN, Conn., May 01, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), will host a conference call on Monday, May 6th, 2019 at 5:00pm Eastern Time to review...
Precipio Signs First Major International Services Contract
29 avr. 2019 08h35 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 29, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) today announced that it has signed a services contract with a health care...
Precipio Launches Global Expansion Strategy
24 avr. 2019 09h01 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 24, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces the launch of Precipio’s global pathology services. The services are...
Mr. Ori Karev Joins Precipio Executive Team As Chief Strategy Officer
18 avr. 2019 08h45 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 18, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) announced today that Mr. Ori Karev has joined the company as its Chief Strategy...
Continued ICP Orders From Japanese Customers
05 mars 2019 07h40 HE
|
Precipio, Inc.
NEW HAVEN, Conn., March 05, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it continues to receive both new and repeat business from...
Precipio Provides Corporate Update Shareholder Call
18 févr. 2019 17h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 18, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), will host a conference call on Thursday, February 21st, 2019 at 4:30pm to review...